U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525986) titled 'Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery' o... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524725) titled 'Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Te... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525531) titled 'Effects of PRF and i-PRF on Clinical and Biochemical Parameters in Non-Surgical Periodonta... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521605) titled 'Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MS... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523542) titled 'SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus' on April 05. Br... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524426) titled 'Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatm... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521800) titled 'Remote ECG Monitoring Post TAVI' on Nov. 24, 2025. Brief Summary: The DRAGON TAVI study i... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524257) titled 'ResQ1010-NSCLC: NAI + Chemoimmunotherapy vs Chemoimmunotherapy for First-Line Advanced/Met... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524439) titled 'Use of a β-Glucan Cream in Incontinence-Associated Dermatitis' on Jan. 29. Brief Sum... Read More
U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524634) titled 'Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunogl... Read More